| Citrate cycle (TCA cycle) |
1.83 |
1.24e-1 |
30/30 (100%) |
PCK1;PCK2;CS;...
|
| Steroid biosynthesis |
1.83 |
6.21e-2 |
19/20 (95%) |
DHCR7;SQLE;TM7SF2;...
|
| Staphylococcus aureus infection |
1.82 |
5.18e-2 |
72/95 (75.79%) |
KRT23;C3;KRT18;...
|
| Vitamin digestion and absorption |
1.77 |
6.99e-2 |
17/24 (70.83%) |
APOB;SLC19A3;SLC19A1;...
|
| Starch and sucrose metabolism |
1.77 |
6.21e-2 |
25/36 (69.44%) |
GPI;UGP2;GYG1;...
|
| Mitophagy |
1.72 |
8.03e-2 |
56/68 (82.35%) |
CITED2;CSNK2B;GABARAPL1;...
|
| Glycolysis / Gluconeogenesis |
1.70 |
9.10e-2 |
56/67 (83.58%) |
PCK1;PGAM1;ALDH3A1;...
|
| Phosphonate and phosphinate metabolism |
1.67 |
1.07e-1 |
5/6 (83.33%) |
CHPT1
|
| Mineral absorption |
1.66 |
1.05e-1 |
48/60 (80%) |
MT1X;MT1G;MT1HL1;...
|
| Bacterial invasion of epithelial cells |
1.66 |
9.63e-2 |
59/77 (76.62%) |
FN1;CAV2;CAV1;...
|
| Tyrosine metabolism |
1.65 |
9.32e-2 |
30/36 (83.33%) |
ALDH3A1;TYR;TYRP1;...
|
| Glyoxylate and dicarboxylate metabolism |
1.64 |
9.58e-2 |
23/30 (76.67%) |
ACAT2;CS;DLD;...
|
| Pyruvate metabolism |
1.64 |
8.84e-2 |
41/47 (87.23%) |
ACAT2;PCK1;PCK2;...
|
| Ferroptosis |
1.64 |
8.54e-2 |
36/41 (87.8%) |
CP;ACSL1;SLC39A14;...
|
| Phenylalanine metabolism |
1.62 |
9.32e-2 |
14/17 (82.35%) |
ALDH3A1;PAH;DDC;...
|
| Valine, leucine and isoleucine degradation |
1.61 |
1.06e-1 |
42/48 (87.5%) |
ACAT2;DLD;MCCC1;...
|
| Galactose metabolism |
1.59 |
1.14e-1 |
26/31 (83.87%) |
AKR1B10;UGP2;PFKL;...
|
| Tryptophan metabolism |
1.56 |
1.45e-1 |
35/42 (83.33%) |
CYP1A1;ACAT2;DLD;...
|
| PPAR signaling pathway |
1.53 |
1.75e-1 |
66/74 (89.19%) |
FABP1;ACSL1;PCK1;...
|
| Estrogen signaling pathway |
1.53 |
1.71e-1 |
119/137 (86.86%) |
MMP9;KRT23;KRT18;...
|
| Bladder cancer |
1.50 |
2.05e-1 |
40/41 (97.56%) |
MMP9;E2F2;DAPK1;...
|
| Shigellosis |
1.48 |
2.15e-1 |
180/246 (73.17%) |
PFN2;C3;FOXO4;...
|
| Nicotine addiction |
1.47 |
2.27e-1 |
32/40 (80%) |
GRIA2;GABRA1;SLC17A6;...
|
| GnRH secretion |
1.46 |
2.33e-1 |
60/64 (93.75%) |
GNA11;PIK3CB;KCNN4;...
|
| Systemic lupus erythematosus |
1.44 |
2.57e-1 |
45/135 (33.33%) |
C3;ACTN1;SNRPB;...
|
| Complement and coagulation cascades |
1.44 |
2.49e-1 |
76/85 (89.41%) |
CLU;C3;CD59;...
|
| Nicotinate and nicotinamide metabolism |
1.43 |
2.55e-1 |
25/35 (71.43%) |
SIRT7;NT5C2;SIRT3;...
|
| Pentose phosphate pathway |
1.42 |
2.60e-1 |
25/30 (83.33%) |
GPI;PGD;TALDO1;...
|
| Collecting duct acid secretion |
1.42 |
2.66e-1 |
22/27 (81.48%) |
ATP6V0E2;ATP6V1D;ATP6V1B2;...
|
| Cell cycle |
1.39 |
3.03e-1 |
110/124 (88.71%) |
PCNA;E2F2;CDC45;...
|
| cGMP-PKG signaling pathway |
-0.85 |
9.14e-1 |
145/167 (86.83%) |
GTF2IRD1;CREB3L1;BAD;...
|
| Coronavirus disease |
-0.85 |
9.08e-1 |
215/232 (92.67%) |
RPS6;RPL7;TLR7;...
|
| ABC transporters |
-0.86 |
9.16e-1 |
37/45 (82.22%) |
ABCD3;ABCC5;ABCB9;...
|
| Vasopressin-regulated water reabsorption |
-0.86 |
9.22e-1 |
40/44 (90.91%) |
ADCY3;AQP3;PRKACB;...
|
| Glioma |
-0.86 |
9.33e-1 |
67/75 (89.33%) |
TGFA;PDGFRB;CALML3;...
|
| Amphetamine addiction |
-1.05 |
9.18e-1 |
57/69 (82.61%) |
PPP1CC;PRKCB;GRIA1;...
|
| Oocyte meiosis |
-1.06 |
9.11e-1 |
90/129 (69.77%) |
MAPK13;INS;CDK1;...
|
| Human papillomavirus infection |
-1.06 |
9.30e-1 |
284/331 (85.8%) |
KRAS;PPP2R2B;TSC1;...
|
| Gap junction |
-1.18 |
8.37e-1 |
72/88 (81.82%) |
PLCB1;MAPK7;CDK1;...
|
| Renin secretion |
-1.19 |
8.13e-1 |
61/69 (88.41%) |
PPP3CC;PRKACB;GUCY1B1;...
|
| Basal cell carcinoma |
-1.21 |
7.75e-1 |
41/63 (65.08%) |
BAX;TCF7;FZD3;...
|
| Transcriptional misregulation in cancer |
-1.22 |
7.69e-1 |
158/192 (82.29%) |
MET;CEBPA;NSD2;...
|
| Chemokine signaling pathway |
-1.23 |
7.35e-1 |
163/192 (84.9%) |
CCL17;AKT1;PRKCB;...
|
| NF-kappa B signaling pathway |
-1.26 |
6.42e-1 |
90/104 (86.54%) |
EDAR;PLAU;PRKCB;...
|
| MicroRNAs in cancer |
-1.27 |
6.44e-1 |
146/310 (47.1%) |
FGFR3;TNN;BCL2L11;...
|
| Type I diabetes mellitus |
-1.27 |
6.86e-1 |
38/43 (88.37%) |
INS;FAS;ICA1;...
|
| Malaria |
-1.27 |
7.29e-1 |
44/50 (88%) |
HBB;TLR4;KLRK1;...
|
| Thiamine metabolism |
-1.30 |
6.47e-1 |
12/15 (80%) |
TPK1;ALPL;AK4;...
|
| Axon guidance |
-1.31 |
6.69e-1 |
151/182 (82.97%) |
PLXNA1;FZD3;EFNA5;...
|
| Wnt signaling pathway |
-1.32 |
7.07e-1 |
124/166 (74.7%) |
CTNND2;SMAD3;CCN4;...
|
| Various types of N-glycan biosynthesis |
-1.37 |
5.31e-1 |
26/39 (66.67%) |
MGAT2;ALG13;MAN1A2;...
|
| Linoleic acid metabolism |
-1.38 |
5.54e-1 |
21/29 (72.41%) |
CYP2E1;PLA2G6;PLA2G1B;...
|
| alpha-Linolenic acid metabolism |
-1.43 |
4.24e-1 |
17/25 (68%) |
PLA2G6;PLA2G1B;PLA2G12A;...
|
| Protein digestion and absorption |
-1.45 |
4.08e-1 |
78/103 (75.73%) |
COL4A1;ELN;CELA3B;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.46 |
4.73e-1 |
84/100 (84%) |
CCL24;CXCR4;CCR1;...
|
| Ether lipid metabolism |
-1.51 |
3.51e-1 |
32/49 (65.31%) |
PLA2G6;PLD3;PLA2G1B;...
|
| Arachidonic acid metabolism |
-1.55 |
3.30e-1 |
48/61 (78.69%) |
GGT1;CYP2E1;PLA2G6;...
|
| Glycosaminoglycan biosynthesis |
-1.58 |
3.34e-1 |
40/58 (68.97%) |
HS3ST2;B3GAT3;CSGALNACT2;...
|
| Ribosome |
-1.61 |
3.64e-1 |
113/158 (71.52%) |
RPL11;RPS6;RPL7;...
|
| Taurine and hypotaurine metabolism |
-1.65 |
5.37e-1 |
8/11 (72.73%) |
GGT1;CDO1;GAD1;...
|
